Developing strategies for psychopharmacological studies in preschool children

Laurence L. Greenhill, Peter S. Jensen, Howard Abikoff, Jeffrey L. Blumer, Joseph DeVeaugh-Geiss, Celia Fisher, Kimberly Hoagwood, Christopher J. Kratochvil, Benjamin B. Lahey, Thomas Laughren, James Leckman, Theodore A. Petti, Kayla Pope, David Shaffer, Benedetto Vitiello, Charles Zeanah

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Objective: To identify the obstacles and special challenges - ethical, practical, scientific, and regulatory - faced by investigators who attempt to conduct psychopharmacological studies in preschoolers. Method: In a workshop held at the 47th Annual Meeting of the American Academy of Child and Adolescent Psychiatry, featuring interactive sessions designed to elicit discussion of the theory and feasibility of research in this young population, several key domains were identified: diagnosis and assessment, ethics, research design, special considerations for preschoolers, regulatory/industry issues, and education/training. Results: A Pediatric Psychopharmacology Initiative is needed to consolidate recommendations from this and other workshops and current federal, research, and regulatory committees. A scholarly review and a guide for institutional review boards and investigators should be prepared on issues related to preschoolers. Developmental specialists provide valuable expertise that can strengthen studies of pediatric psychopharmacology. "N of 1" case studies can provide valuable information to clinicians. Only preschoolers with severe symptoms that occur in several interpersonal contexts should be entered into trials. Indications for the study of symptom complexes (e.g., aggression) rather than specific diagnoses should be examined and considered for regulatory activities. Psychopharmacology practice parameters for preschoolers are needed. Conclusions: With preschoolers being increasingly treated with psychopharmacological agents, the need for investigations to address the safety and efficacy of these medications is becoming a central issue for researchers from many disciplines.

Original languageEnglish (US)
Pages (from-to)406-414
Number of pages9
JournalJournal of the American Academy of Child and Adolescent Psychiatry
Volume42
Issue number4
DOIs
StatePublished - Jan 1 2003
Externally publishedYes

Fingerprint

Psychopharmacology
Preschool Children
Research Personnel
Education
Pediatrics
Adolescent Psychiatry
Child Psychiatry
Research Ethics Committees
Aggression
Research
Ethics
Industry
Research Design
Safety
Population

All Science Journal Classification (ASJC) codes

  • Developmental and Educational Psychology
  • Psychiatry and Mental health

Cite this

Greenhill, L. L., Jensen, P. S., Abikoff, H., Blumer, J. L., DeVeaugh-Geiss, J., Fisher, C., ... Zeanah, C. (2003). Developing strategies for psychopharmacological studies in preschool children. Journal of the American Academy of Child and Adolescent Psychiatry, 42(4), 406-414. https://doi.org/10.1097/01.CHI.0000046812.95464.FA

Developing strategies for psychopharmacological studies in preschool children. / Greenhill, Laurence L.; Jensen, Peter S.; Abikoff, Howard; Blumer, Jeffrey L.; DeVeaugh-Geiss, Joseph; Fisher, Celia; Hoagwood, Kimberly; Kratochvil, Christopher J.; Lahey, Benjamin B.; Laughren, Thomas; Leckman, James; Petti, Theodore A.; Pope, Kayla; Shaffer, David; Vitiello, Benedetto; Zeanah, Charles.

In: Journal of the American Academy of Child and Adolescent Psychiatry, Vol. 42, No. 4, 01.01.2003, p. 406-414.

Research output: Contribution to journalArticle

Greenhill, LL, Jensen, PS, Abikoff, H, Blumer, JL, DeVeaugh-Geiss, J, Fisher, C, Hoagwood, K, Kratochvil, CJ, Lahey, BB, Laughren, T, Leckman, J, Petti, TA, Pope, K, Shaffer, D, Vitiello, B & Zeanah, C 2003, 'Developing strategies for psychopharmacological studies in preschool children', Journal of the American Academy of Child and Adolescent Psychiatry, vol. 42, no. 4, pp. 406-414. https://doi.org/10.1097/01.CHI.0000046812.95464.FA
Greenhill, Laurence L. ; Jensen, Peter S. ; Abikoff, Howard ; Blumer, Jeffrey L. ; DeVeaugh-Geiss, Joseph ; Fisher, Celia ; Hoagwood, Kimberly ; Kratochvil, Christopher J. ; Lahey, Benjamin B. ; Laughren, Thomas ; Leckman, James ; Petti, Theodore A. ; Pope, Kayla ; Shaffer, David ; Vitiello, Benedetto ; Zeanah, Charles. / Developing strategies for psychopharmacological studies in preschool children. In: Journal of the American Academy of Child and Adolescent Psychiatry. 2003 ; Vol. 42, No. 4. pp. 406-414.
@article{a331573b33be4d4ca1c0c71a6e56109d,
title = "Developing strategies for psychopharmacological studies in preschool children",
abstract = "Objective: To identify the obstacles and special challenges - ethical, practical, scientific, and regulatory - faced by investigators who attempt to conduct psychopharmacological studies in preschoolers. Method: In a workshop held at the 47th Annual Meeting of the American Academy of Child and Adolescent Psychiatry, featuring interactive sessions designed to elicit discussion of the theory and feasibility of research in this young population, several key domains were identified: diagnosis and assessment, ethics, research design, special considerations for preschoolers, regulatory/industry issues, and education/training. Results: A Pediatric Psychopharmacology Initiative is needed to consolidate recommendations from this and other workshops and current federal, research, and regulatory committees. A scholarly review and a guide for institutional review boards and investigators should be prepared on issues related to preschoolers. Developmental specialists provide valuable expertise that can strengthen studies of pediatric psychopharmacology. {"}N of 1{"} case studies can provide valuable information to clinicians. Only preschoolers with severe symptoms that occur in several interpersonal contexts should be entered into trials. Indications for the study of symptom complexes (e.g., aggression) rather than specific diagnoses should be examined and considered for regulatory activities. Psychopharmacology practice parameters for preschoolers are needed. Conclusions: With preschoolers being increasingly treated with psychopharmacological agents, the need for investigations to address the safety and efficacy of these medications is becoming a central issue for researchers from many disciplines.",
author = "Greenhill, {Laurence L.} and Jensen, {Peter S.} and Howard Abikoff and Blumer, {Jeffrey L.} and Joseph DeVeaugh-Geiss and Celia Fisher and Kimberly Hoagwood and Kratochvil, {Christopher J.} and Lahey, {Benjamin B.} and Thomas Laughren and James Leckman and Petti, {Theodore A.} and Kayla Pope and David Shaffer and Benedetto Vitiello and Charles Zeanah",
year = "2003",
month = "1",
day = "1",
doi = "10.1097/01.CHI.0000046812.95464.FA",
language = "English (US)",
volume = "42",
pages = "406--414",
journal = "Journal of the American Academy of Child and Adolescent Psychiatry",
issn = "0890-8567",
publisher = "Elsevier Limited",
number = "4",

}

TY - JOUR

T1 - Developing strategies for psychopharmacological studies in preschool children

AU - Greenhill, Laurence L.

AU - Jensen, Peter S.

AU - Abikoff, Howard

AU - Blumer, Jeffrey L.

AU - DeVeaugh-Geiss, Joseph

AU - Fisher, Celia

AU - Hoagwood, Kimberly

AU - Kratochvil, Christopher J.

AU - Lahey, Benjamin B.

AU - Laughren, Thomas

AU - Leckman, James

AU - Petti, Theodore A.

AU - Pope, Kayla

AU - Shaffer, David

AU - Vitiello, Benedetto

AU - Zeanah, Charles

PY - 2003/1/1

Y1 - 2003/1/1

N2 - Objective: To identify the obstacles and special challenges - ethical, practical, scientific, and regulatory - faced by investigators who attempt to conduct psychopharmacological studies in preschoolers. Method: In a workshop held at the 47th Annual Meeting of the American Academy of Child and Adolescent Psychiatry, featuring interactive sessions designed to elicit discussion of the theory and feasibility of research in this young population, several key domains were identified: diagnosis and assessment, ethics, research design, special considerations for preschoolers, regulatory/industry issues, and education/training. Results: A Pediatric Psychopharmacology Initiative is needed to consolidate recommendations from this and other workshops and current federal, research, and regulatory committees. A scholarly review and a guide for institutional review boards and investigators should be prepared on issues related to preschoolers. Developmental specialists provide valuable expertise that can strengthen studies of pediatric psychopharmacology. "N of 1" case studies can provide valuable information to clinicians. Only preschoolers with severe symptoms that occur in several interpersonal contexts should be entered into trials. Indications for the study of symptom complexes (e.g., aggression) rather than specific diagnoses should be examined and considered for regulatory activities. Psychopharmacology practice parameters for preschoolers are needed. Conclusions: With preschoolers being increasingly treated with psychopharmacological agents, the need for investigations to address the safety and efficacy of these medications is becoming a central issue for researchers from many disciplines.

AB - Objective: To identify the obstacles and special challenges - ethical, practical, scientific, and regulatory - faced by investigators who attempt to conduct psychopharmacological studies in preschoolers. Method: In a workshop held at the 47th Annual Meeting of the American Academy of Child and Adolescent Psychiatry, featuring interactive sessions designed to elicit discussion of the theory and feasibility of research in this young population, several key domains were identified: diagnosis and assessment, ethics, research design, special considerations for preschoolers, regulatory/industry issues, and education/training. Results: A Pediatric Psychopharmacology Initiative is needed to consolidate recommendations from this and other workshops and current federal, research, and regulatory committees. A scholarly review and a guide for institutional review boards and investigators should be prepared on issues related to preschoolers. Developmental specialists provide valuable expertise that can strengthen studies of pediatric psychopharmacology. "N of 1" case studies can provide valuable information to clinicians. Only preschoolers with severe symptoms that occur in several interpersonal contexts should be entered into trials. Indications for the study of symptom complexes (e.g., aggression) rather than specific diagnoses should be examined and considered for regulatory activities. Psychopharmacology practice parameters for preschoolers are needed. Conclusions: With preschoolers being increasingly treated with psychopharmacological agents, the need for investigations to address the safety and efficacy of these medications is becoming a central issue for researchers from many disciplines.

UR - http://www.scopus.com/inward/record.url?scp=0037899878&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037899878&partnerID=8YFLogxK

U2 - 10.1097/01.CHI.0000046812.95464.FA

DO - 10.1097/01.CHI.0000046812.95464.FA

M3 - Article

VL - 42

SP - 406

EP - 414

JO - Journal of the American Academy of Child and Adolescent Psychiatry

JF - Journal of the American Academy of Child and Adolescent Psychiatry

SN - 0890-8567

IS - 4

ER -